Trends in Antipsychotic Prescribing in Medicaid-Eligible Youth von Edelsohn, Gail A., MD, MSPH, Karpov, Irina, MS, Parthasarathy, Meghna, MS, Hutchinson, Shari L., MS, Castelnovo, Kim, RPh, Ghuman, Jaswinder, MD, Schuster, James M., MD, MBA

Volltext

Risperidone for the Core Symptom Domains of Autism: Results From the Study by the Autism Network of the Research Units on Pediatric Psychopharmacology von McDougle, Christopher J., Scahill, Lawrence, Aman, Michael G., McCracken, James T., Tierney, Elaine, Davies, Mark, Arnold, L. Eugene, Posey, David J., Martin, Andrès, Ghuman, Jaswinder K., Shah, Bhavik, Chuang, Shirley Z., Swiezy, Naomi B., Gonzalez, Nilda M., Hollway, Jill, Koenig, Kathleen, McGough, James J., Ritz, Louise, Vitiello, Benedetto

Volltext

Efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in patients with common comorbidities in children, adolescents and adults: a review von Hutchison, Shari L., Ghuman, Jaswinder K., Ghuman, Harinder S., Karpov, Irina, Schuster, James M.

Volltext

Pharmacologic Intervention for Attention-Deficit Hyperactivity Disorder in Preschoolers: Is It Justified? von Ghuman, Jaswinder K., Ghuman, Harinder S.

Volltext

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders von Ghuman, Jaswinder K, Aman, Michael G, Lecavalier, Luc, Riddle, Mark A, Gelenberg, Alan, Wright, Ron, Rice, Sydney, Ghuman, Harinder S, Fort, Carolyn

Volltext

Pharmacological Treatment of Attention Deficit Hyperactivity Disorder in Children and Adolescents: Clinical Strategies von Shier, Anna C., Reichenbacher, Thomas, Ghuman, Harinder S., Ghuman, Jaswinder K.

Volltext

5.59 TRENDS IN ANTIPSYCHOTIC PRESCRIBING IN MEDICAID-ELIGIBLE YOUTH von Edelsohn, Gail A., MD, MSPH, Karpov, Irina, MS, Parthasarathy, Meghna, MS, Hutchison, Shari L., MS, Castelnovo, Kim, RPH, Ghuman, Jaswinder, MD, Schuster, James M., MD, MBA

Volltext

3.52 MEDICATIONS, DIAGNOSES, AND PRESCRIBERS: WHAT WE KNOW ABOUT PUBLICLY FUNDED PRESCHOOLERS ON PSYCHOTROPIC MEDICATIONS von Ghuman, Jaswinder, MD, Edelsohn, Gail A., MD, MSPH, Martin, Vicki, MD, Karpov, Irina, MS, Parthasarathy, Meghna, MS, Hutchison, Shari L., MS, Castelnovo, Kim, RPH

Volltext

Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice von Ghuman, Jaswinder K, Arnold, L Eugene, Anthony, Bruno J

Volltext

The screen for social interaction (SSI): A screening measure for autism spectrum disorders in preschoolers von Ghuman, Jaswinder K., Leone, Sarah L., Lecavalier, Luc, Landa, Rebecca J.

Volltext

Atomoxetine is a second-line medication treatment option for ADHD von Ghuman, Jaswinder K, Hutchison, Shari L

Volltext

Acute and long-term safety and tolerability of risperidone in children with autism von Aman, Michael G, Arnold, L Eugene, McDougle, Christopher J, Vitiello, Benedetto, Scahill, Lawrence, Davies, Mark, McCracken, James T, Tierney, Elaine, Nash, Patricia L, Posey, David J, Chuang, Shirley, Martin, Andres, Shah, Bhavik, Gonzalez, Nilda M, Swiezy, Naomi B, Ritz, Louise, Koenig, Kathleen, McGough, James, Ghuman, Jaswinder K, Lindsay, Ronald L

Volltext

Cognitive effects of risperidone in children with autism and irritable behavior von Aman, Michael G, Hollway, Jill A, McDougle, Christopher J, Scahill, Lawrence, Tierney, Elaine, McCracken, James T, Arnold, L Eugene, Vitiello, Benedetto, Ritz, Louise, Gavaletz, Allison, Cronin, Pegeen, Swiezy, Naomi, Wheeler, Courtney, Koenig, Kathleen, Ghuman, Jaswinder K, Posey, David J

Volltext

Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder von Ghuman, Jaswinder K, Aman, Michael G, Ghuman, Harinder S, Reichenbacher, Thomas, Gelenberg, Alan, Wright, Ron, Rice, Sydney, Fort, Carolyn

Volltext

Behavioral training for pill-swallowing difficulties in young children with autistic disorder von Ghuman, Jaswinder K, Cataldo, Marilyn D, Beck, Melissa H, Slifer, Keith J

Volltext

Restricted elimination diet for ADHD: the INCA study von Ghuman, Jaswinder Kaur

Volltext

Efficacy and Safety of Immediate-Release Methylphenidate Treatment for Preschoolers With ADHD von GREENHILL, LAURENCE, KOLLINS, SCOTT, ABIKOFF, HOWARD, MCCRACKEN, JAMES, RIDDLE, MARK, SWANSON, JAMES, MCGOUGH, JAMES, WIGAL, SHARON, WIGAL, TIM, VITIELLO, BENEDETTO, SKROBALA, ANNE, POSNER, KELLY, GHUMAN, JASWINDER, CUNNINGHAM, CHARLES, DAVIES, MARK, CHUANG, SHIRLEY, COOPER, TOM

Volltext

1.43 Psychotropic Medication Utilization in Medicaid-Eligible Children Ages 0-2 Years: Longitudinal View von Edelsohn, Gail Ann, Ghuman, Jaswinder, Martin, Vicki, Hutchison, Shari L., Karpov, Irina, Parthasarathy, Meghna, Castelnovo, Kim

Volltext

Safety and Tolerability of Methylphenidate in Preschool Children With ADHD von WIGAL, TIM, GREENHILL, LAURENCE, CHUANG, SHIRLEY, McGOUGH, JAMES, VITIELLO, BENEDETTO, SKROBALA, ANNE, SWANSON, JAMES, WIGAL, SHARON, ABIKOFF, HOWARD, KOLLINS, SCOTT, McCRACKEN, JAMES, RIDDLE, MARK, POSNER, KELLY, GHUMAN, JASWINDER, DAVIES, MARK, THORP, BEN, STEHLI, ANNAMARIE

Volltext

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial von Aman, Michael, Rettiganti, Mallikarjuna, Nagaraja, Haikady N, Hollway, Jill A, McCracken, James, McDougle, Christopher J, Tierney, Elaine, Scahill, Lawrence, Arnold, L Eugene, Hellings, Jessica, Posey, David J, Swiezy, Naomi B, Ghuman, Jaswinder, Grados, Marco, Shah, Bhavik, Vitiello, Benedetto

Volltext